New Key Statistics Module, Z-Score and F-Score
XCNQ:AREV Key Ratios
| Market Cap C$ M | 2.84 |
| Enterprise Value C$ M | 2.87 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) C$ M | -- |
| EPS (TTM) C$ | -0.01 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -- |
| EV-to-EBITDA | -- |
| PEG | -- |
| Shares Outstanding M | 31.76 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | -- |
| Current Ratio | -- |
| ROA % (ttm) | -- |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -- |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
XCNQ:AREV Number of Guru Trades
XCNQ:AREV Volume of Guru Trades
Gurus Latest Trades with XCNQ:AREV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:AREV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AREV Life Sciences Global Corp Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers